Search Results (205)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Cubanes in medicinal chemistry: synthesis of functionalized building blocks. | Academic Article |
Why?
|
| Max Bergmann award lecture:Macromolecular medicinal chemistry as applied to metabolic diseases. | Academic Article |
Why?
|
| Randolph, Theodore | Person |
Why?
|
| Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry. | Academic Article |
Why?
|
| Chemistry, Pharmaceutical | Concept |
Why?
|
| Henen, Morkos | Person |
Why?
|
| Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics. | Academic Article |
Why?
|
| Combinatorial drug discovery: which methods will produce the greatest value? | Academic Article |
Why?
|
| DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity. | Academic Article |
Why?
|
| Electrochemical determination of dissolution rates of lyophilized pharmaceutical formulations. | Academic Article |
Why?
|
| Enabling Efficient Design of Biological Formulations through Advanced Characterizations. | Academic Article |
Why?
|
| High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics. | Academic Article |
Why?
|
| Rapid Quantification of Protein Particles in High-Concentration Antibody Formulations. | Academic Article |
Why?
|
| Common excipients impair detection of protein aggregates during sedimentation velocity analytical ultracentrifugation. | Academic Article |
Why?
|
| Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist. | Academic Article |
Why?
|